MRPL53 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.566000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.305800E-01
Normal-vs-Stage2
9.675400E-01
Normal-vs-Stage3
9.908000E-01
Normal-vs-Stage4
8.290600E-01
Stage1-vs-Stage2
9.416200E-01
Stage1-vs-Stage3
9.554000E-01
Stage1-vs-Stage4
9.530200E-01
Stage2-vs-Stage3
9.806400E-01
Stage2-vs-Stage4
6.916800E-01
Stage3-vs-Stage4
9.338600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.126800E-01
Normal-vs-AfricanAmerican
8.524800E-01
Normal-vs-Asian
9.847000E-01
Caucasian-vs-AfricanAmerican
6.210600E-01
Caucasian-vs-Asian
8.685400E-01
AfricanAmerican-vs-Asian
7.774800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.974400E-01
Normal-vs-Female
9.066000E-01
Male-vs-Female
6.195400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.867600E-01
Normal-vs-Age(41-60Yrs)
9.784400E-01
Normal-vs-Age(61-80Yrs)
9.783000E-01
Normal-vs-Age(81-100Yrs)
4.088800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.025600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.730200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.394400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
8.530600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.714810E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.883200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.658800E-01
Normal-vs-Daily Drinker
5.448600E-01
Normal-vs-Weekly Drinker
8.937800E-01
Normal-vs-Occasional Drinker
5.861800E-01
Normal-vs-Social Drinker
9.190800E-01
Non Drinker-vs-Daily Drinker
1.947600E-01
Non Drinker-vs-Weekly Drinker
8.553600E-01
Non Drinker-vs-Occasional Drinker
2.399400E-01
Non Drinker-vs-Social Drinker
7.577600E-01
Daily Drinker-vs-Weekly Drinker
3.801000E-01
Daily Drinker-vs-Occasional Drinker
7.810200E-01
Daily Drinker-vs-Social Drinker
2.371800E-01
Weekly Drinker-vs-Occasional Drinker
3.700800E-01
Weekly Drinker-vs-Social Drinker
7.104400E-01
Occasional Drinker-vs-Social Drinker
2.524400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.198400E-01
Normal-vs-Grade 2
3.106200E-01
Normal-vs-Grade 3
1.997560E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.603200E-01
Grade 1-vs-Grade 3
7.389400E-01
Grade 1-vs-Grade 4
5.198400E-01
Grade 2-vs-Grade 3
1.231180E-01
Grade 2-vs-Grade 4
3.106200E-01
Grade 3-vs-Grade 4
1.997560E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.822000E-01
Normal-vs-NonDiabetic
8.168800E-01
Diabetic-vs-NonDiabetic
9.349200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.877600E-01
Normal-vs-NoPancreatitis
8.842800E-01
Pancreatitis-vs-NoPancreatitis
3.537900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.238400E-01
Normal-vs-N1
8.992800E-01
N0-vs-N1
1.012010E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.593000E-01
Normal-vs-TP53-NonMutant
7.378200E-01
TP53-Mutant-vs-TP53-NonMutant
1.639240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
